Pilot Project

$46,354P50FY2015AANIH

University Of California, San Francisco, San Francisco CA

Investigators

Linked publications & trials

Paper 33420199 Paper 31820733 Paper 31678994 Paper 30814925 Paper 30808819 Paper 30536923 Paper 30449884 Paper 30038277 Paper 30022576 Paper 29909248 Paper 29726054 Paper 29691979 Paper 29654346 Paper 29497165 Paper 29310048 Paper 29198469 Paper 28912680 Paper 28890345 Paper 28696243 Paper 28683314 Paper 28681511 Paper 28292440 Paper 28103636 Paper 27906494 Paper 27788780 Paper 27766766 Paper 27706932 Paper 27683907 Paper 27625592 Paper 27523303 Paper 27452469 Paper 27444358 Paper 27279227 Paper 26952865 Paper 26947945 Paper 26893192 Paper 26791202 Paper 26733798 Paper 26290240 Paper 26204799 Paper 25992601 Paper 25801502 Paper 25801118 Paper 25592533 Paper 25330738 Paper 24865944 Paper 24811154 Paper 24733061 Paper 24721195 Paper 24666346 Paper 24588427 Paper 24498174 Paper 24215342 Paper 24005290 Paper 23915285 Paper 23905844 Paper 23817545 Paper 23792945 Paper 23708143 Paper 23649885 Paper 23423140 Paper 23283171 Paper 23227189 Paper 23136424 Paper 23100433 Paper 23097213 Paper 22883308 Paper 22853648 Paper 22708955 Paper 22574271 Paper 22337177 Paper 22153370 Paper 22018601 Paper 21889123 Paper 21877259 Paper 21690191 Paper 21549353 Paper 21248138 Paper 21041654 Paper 21039633 Paper 20605909 Paper 20350291 Paper 19951294 Paper 18991950

Abstract

The Pilot Project Component is designed to provide a flexible means for developing and exploring new research activities or directions, and unique opportunities that can evolve into independently funded research projects. During Years 6-10 we propose funding two pilot projects per year with a budget of about $50,000 per project. The expected duration of these projects will be 1 year; projects can be extended to two years upon successful competitive renewal. The Center Scientific Director will manage this Component. Pilot Project applications will be solicited annually from EGCRC and UCSF investigators. Each proposal will be evaluated for scientific merit, innovation, and for relatedness to the Center's overall goals by at least two members of the ACTG Program Advisory Board, the Scientific Director, and the Center Director. Recommendations for funding will be considered for approval by the Center Steering Committee. Two Pilot Projects have been proposed and awarded funding for Year 06.Project 7A (A. Kayser, Director) will examine whether the Delta Opioid Receptor (DOR) agonist, ALK33, can be a potential drug to treat alcohol intake and craving in a preclinical human trial. Experiments in human subjects are also aimed to conducted fMRI studies to determine whether the increase the connectivity between the medial prefrontal cortex and brain regions associated with reward and anxiety.

View original record on NIH RePORTER →